Jeong Seol-Ha, Kang Jae Jun, Kim Ki-Myo, Lee Mi Hyun, Cha Misun, Kim Su Hee, Park Ji-Ung
Department of Plastic and Reconstructive Surgery, Seoul National University Boramae Hospital, Seoul National University College of Medicine, Seoul, 07061, Republic of Korea.
Bio-max Institute, Seoul National University, Seoul, 08826, Republic of Korea.
Adv Healthc Mater. 2025 Apr;14(11):e2403213. doi: 10.1002/adhm.202403213. Epub 2025 Mar 20.
To address the demand for reconstructive procedures in extensive subcutaneous tissue defects and significant dermis matrix loss, vascularized adipose tissue regeneration is essential for maintaining volume after material degradation. Accordingly, a double-crosslinked hydrogel that combines polyethylene glycol (PEG)-crosslinked carboxymethyl chitosan (CMC) with a hybrid decellularized extracellular matrix (dECM) is developed. The dECM, sourced from porcine adipose and cardiac tissues, processed using a supercritical fluid technique (scCO-EtOH) retains 1.5-5-fold more angiogenic and adipogenic cytokines than that processed using traditional methods. This hybrid dECM-based filler demonstrates excellent physical properties and injectability, with injection forces being significantly less than that for crosslinked hyaluronic acid (HA) fillers. Upon incubation at 37 °C, the storage modulus of the fillers increases substantially, eventually enhancing their moldability from additional crosslinking and the thermosensitive nature of collagen. Assessments in a UVB-induced photoaging mouse model indicate that the material maintains superior shape stability, durability, and supports vascularized tissue regeneration, reduces inflammation, and enhances VEGF expression and ECM maturation more effectively compared with that using other fillers. These promising results suggest that the material can serve as a highly effective multifunctional solution for injectable regenerative medical applications and is well-suited for potential clinical trials.
为满足大面积皮下组织缺损和显著真皮基质缺失的重建手术需求,血管化脂肪组织再生对于材料降解后维持体积至关重要。因此,开发了一种双交联水凝胶,它将聚乙二醇(PEG)交联的羧甲基壳聚糖(CMC)与混合脱细胞细胞外基质(dECM)相结合。源自猪脂肪和心脏组织、采用超临界流体技术(scCO-EtOH)处理的dECM,比采用传统方法处理的dECM保留的血管生成和成脂细胞因子多1.5至5倍。这种基于混合dECM的填充剂具有优异的物理性能和可注射性,注射力明显小于交联透明质酸(HA)填充剂。在37°C孵育时,填充剂的储能模量大幅增加,最终由于额外的交联和胶原蛋白的热敏性质而增强其可模塑性。在紫外线B诱导的光老化小鼠模型中的评估表明,与使用其他填充剂相比,该材料保持了优异的形状稳定性、耐久性,支持血管化组织再生,减少炎症,并更有效地增强血管内皮生长因子(VEGF)表达和细胞外基质成熟。这些有前景的结果表明,该材料可作为注射式再生医学应用的高效多功能解决方案,非常适合潜在的临床试验。